Trained as both a physician and engineer, Bhatia is a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science. Her laboratory is dedicated to leveraging miniaturization tools from the world of semiconductor manufacturing to impact human health. She has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics, and drug delivery. Her team has developed human microlivers that model human drug metabolism, liver disease, and interaction with pathogens. The group also develops nanoparticles and nanoporous materials that can be designed to study, diagnose, and treat cancer and other diseases.
Bhatia earned a bachelor’s degree from Brown University, a PhD from MIT, and an MD from Harvard University. She is also a Howard Hughes Medical Institute investigator, an affiliated faculty member of the Harvard Stem Cell Institute, an institute member of the Broad Institute, and a biomedical engineer at the Brigham and Women's Hospital. She is an elected member of the National Academy of Engineering, the American Academy of Arts and Sciences, and the National Academy of Inventors. Her many awards include the 2014 Lemelson-MIT Prize; the 20th Heinz Award for Technology, the Economy, and Employment; the David and Lucile Packard Fellowship; and the NSF CAREER Award.